Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q553220> ?p ?o }
Showing triples 1 to 72 of
72
with 100 triples per page.
- Q553220 subject Q8253301.
- Q553220 subject Q8297717.
- Q553220 subject Q8343668.
- Q553220 subject Q8808791.
- Q553220 abstract "Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz. It is structurally very similar to meropenem in that it possesses a 1-β-methyl group. Other members of the carbapenem group (imipenem, doripenem, and meropenem) are broadly active antibacterials that are used for infections caused by difficult to treat or multidrug-resistant bacteria (such as ESBL expressing Klebsiella pneumonia). They have very short serum half-lives and must be administered by intravenous infusion every 6 to 8 hours. Ertapenem differs from other carbapenems in having a somewhat less broad spectrum of activity (not against Pseudomonas aeruginosa), and in that its extended serum half-life allows it to be administered once every 24 hours.".
- Q553220 atcPrefix "J01".
- Q553220 atcSuffix "DH03".
- Q553220 bioavailability "90.0".
- Q553220 casNumber "153832-46-3".
- Q553220 chEBI "404903".
- Q553220 drugbank "DB00303".
- Q553220 fdaUniiCode "G32F6EID2H".
- Q553220 iupacName "(4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]".
- Q553220 iupacName "oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid".
- Q553220 iupacName "pyrrolidin-3-yl]sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-".
- Q553220 pubchem "150610".
- Q553220 thumbnail Ertapenem_Formula_V.1.svg?width=300.
- Q553220 wikiPageWikiLink Q103135.
- Q553220 wikiPageWikiLink Q10876.
- Q553220 wikiPageWikiLink Q12187.
- Q553220 wikiPageWikiLink Q168800.
- Q553220 wikiPageWikiLink Q185557.
- Q553220 wikiPageWikiLink Q189790.
- Q553220 wikiPageWikiLink Q216935.
- Q553220 wikiPageWikiLink Q244150.
- Q553220 wikiPageWikiLink Q247489.
- Q553220 wikiPageWikiLink Q30515.
- Q553220 wikiPageWikiLink Q310457.
- Q553220 wikiPageWikiLink Q311379.
- Q553220 wikiPageWikiLink Q31856.
- Q553220 wikiPageWikiLink Q391744.
- Q553220 wikiPageWikiLink Q407693.
- Q553220 wikiPageWikiLink Q410897.
- Q553220 wikiPageWikiLink Q411552.
- Q553220 wikiPageWikiLink Q41803.
- Q553220 wikiPageWikiLink Q41873.
- Q553220 wikiPageWikiLink Q421670.
- Q553220 wikiPageWikiLink Q425152.
- Q553220 wikiPageWikiLink Q432083.
- Q553220 wikiPageWikiLink Q45959.
- Q553220 wikiPageWikiLink Q47270.
- Q553220 wikiPageWikiLink Q48143.
- Q553220 wikiPageWikiLink Q517258.
- Q553220 wikiPageWikiLink Q574905.
- Q553220 wikiPageWikiLink Q595158.
- Q553220 wikiPageWikiLink Q632006.
- Q553220 wikiPageWikiLink Q640448.
- Q553220 wikiPageWikiLink Q6420046.
- Q553220 wikiPageWikiLink Q8253301.
- Q553220 wikiPageWikiLink Q8297717.
- Q553220 wikiPageWikiLink Q8343668.
- Q553220 wikiPageWikiLink Q8808791.
- Q553220 wikiPageWikiLink Q9377.
- Q553220 atcPrefix "J01".
- Q553220 atcSuffix "DH03".
- Q553220 bioavailability "90.0".
- Q553220 casNumber "153832".
- Q553220 chebi "404903".
- Q553220 drugbank "DB00303".
- Q553220 iupacName "-3".
- Q553220 iupacName "oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid".
- Q553220 iupacName "pyrrolidin-3-yl]sulfanyl-6--4-methyl-7-".
- Q553220 pubchem "150610".
- Q553220 unii "G32F6EID2H".
- Q553220 type ChemicalSubstance.
- Q553220 type Drug.
- Q553220 type ChemicalObject.
- Q553220 type Thing.
- Q553220 type Q8386.
- Q553220 comment "Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz. It is structurally very similar to meropenem in that it possesses a 1-β-methyl group. Other members of the carbapenem group (imipenem, doripenem, and meropenem) are broadly active antibacterials that are used for infections caused by difficult to treat or multidrug-resistant bacteria (such as ESBL expressing Klebsiella pneumonia).".
- Q553220 label "Ertapenem".
- Q553220 depiction Ertapenem_Formula_V.1.svg.